Variant report
Variant | esv3318538 |
---|---|
Chromosome Location | chr19:40665300-40666305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8106007 | chr19:40665301-40665302 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550939421 | chr19:40665310-40665311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs8106012 | chr19:40665311-40665312 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs533825029 | chr19:40665352-40665353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555382374 | chr19:40665355-40665356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573735255 | chr19:40665379-40665380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs8105260 | chr19:40665440-40665441 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs557393151 | chr19:40665441-40665442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575793253 | chr19:40665519-40665520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146544819 | chr19:40665562-40665563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181960743 | chr19:40665611-40665612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573318202 | chr19:40665637-40665638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540882367 | chr19:40665641-40665642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141218764 | chr19:40665681-40665682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs16974108 | chr19:40665727-40665728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73553624 | chr19:40665776-40665777 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs562767737 | chr19:40665792-40665793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs60202524 | chr19:40665857-40665858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76666735 | chr19:40665871-40665872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs474481 | chr19:40665924-40665925 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs57484453 | chr19:40665947-40665948 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs621232 | chr19:40665957-40665958 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs143169307 | chr19:40666017-40666018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567134778 | chr19:40666018-40666019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549233353 | chr19:40666020-40666021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188843073 | chr19:40666029-40666030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567465115 | chr19:40666030-40666031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538175781 | chr19:40666034-40666035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371934069 | chr19:40666043-40666044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376814588 | chr19:40666079-40666080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79710624 | chr19:40666108-40666109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571516702 | chr19:40666142-40666143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528341500 | chr19:40666173-40666174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140409844 | chr19:40666195-40666196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546599934 | chr19:40666283-40666284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558295002 | chr19:40666303-40666304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Lung cancer | 21569311 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Genital abnormality | 22378287 | CNVD |
Hypospadia | 22378287 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:40654200-40673400 | Weak transcription | Right Atrium | heart |
2 | chr19:40659600-40667400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr19:40659600-40667600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr19:40661000-40667400 | Weak transcription | Primary B cells from cord blood | blood |
5 | chr19:40662000-40667600 | Weak transcription | Primary B cells from peripheral blood | blood |
6 | chr19:40662000-40667600 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
7 | chr19:40662200-40667800 | Weak transcription | GM12878-XiMat | blood |
8 | chr19:40662600-40667600 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
9 | chr19:40663200-40668600 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
10 | chr19:40663600-40666200 | Enhancers | HepG2 | liver |
11 | chr19:40663800-40667400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
12 | chr19:40665000-40665400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
13 | chr19:40665400-40669400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr19:40665600-40666400 | Enhancers | Ovary | ovary |
15 | chr19:40666200-40667600 | Weak transcription | HepG2 | liver |